Open Accesspp32 overexpression induces nuclear pleomorphism in rat prostatic carcinoma cells
Author(s) -
Gusev Y.,
Romantsev F. E.,
Chen T. T.H.,
Kayler A. E.,
Kuhajda F. P.,
Dooley W. C.,
Pasternack G. R.
Publication year - 1996
Publication title -
cell proliferation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.647
H-Index - 74
eISSN - 1365-2184
pISSN - 0960-7722
DOI - 10.1111/j.1365-2184.1996.tb00978.x
Subject(s) - pleomorphism (cytology) , carcinoma cell , biology , carcinoma , cancer research , pathology , medicine , immunology , immunohistochemistry
. Nuclear pleomorphism is an important diagnostic factor in tumour pathology. Traditionally, nuclear pleomorphism is evaluated qualitatively or semiquantitatively, often as a component of tumour grade; the molecular basis of nuclear pleomorphism, however, remains unclear. In this study, we investigated the quantitative effects on nuclear morphology of overexpressing pp32, a recently described nuclear phosphoprotein highly expressed in self‐renewing and neoplastic cell populations. Assessment of Feulgen‐stained transfected and control lines of AT3.1, a rat prostatic carcinoma cell line, using a computerized Cellular Image Analysis System (BD CAS‐200) showed that stable overexpression of human pp32 in AT3.1 cells is accompanied by marked increases in the coefficient of variation of nuclear shape, nuclear size and chromatin textures but not in DNA content. In contrast, stable transfection with control vector, with ras , or with bcl‐2 failed to affect nuclear morphology. Cell cycle analysis further showed that pp32‐related increases in variation of nuclear structure manifested principally in G 1. These studies suggest that pp32 plays a role either directly or indirectly in the control of nuclear shape of G 1 cells.